Cargando…
Potential of immunosuppressive agents in cerebral ischaemia
Ischaemic stroke is a disorder involving multiple mechanisms of injury progression including activation of glutamate receptors, release of proinflammatory cytokines, nitric oxide (NO), free oxygen radicals and proteases. Presently, recombinant tissue plasminogen activator (rtPA) is the only drug app...
Autores principales: | Gupta, Yogendra Kumar, Chauhan, Anjali |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100142/ https://www.ncbi.nlm.nih.gov/pubmed/21321416 |
Ejemplares similares
-
Crosstalk Between Autophagy and Inflammation in Chronic Cerebral Ischaemia
por: Zhou, Hai-qian, et al.
Publicado: (2023) -
Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage
por: Flynn, Liam, et al.
Publicado: (2015) -
Risk of bias reporting in the recent animal focal cerebral ischaemia literature
por: Bahor, Zsanett, et al.
Publicado: (2017) -
Toll-Like Receptors in Ischaemia and Its Potential Role in the Pathophysiology of Muscle Damage in Critical Limb Ischaemia
por: Patel, Hemanshu, et al.
Publicado: (2012) -
Evaluating the translational potential of progesterone treatment following transient cerebral ischaemia in male mice
por: Wong, Raymond, et al.
Publicado: (2014)